SMTI Sanara MedTech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SMTI

Price (delayed)

$32.44

Market cap

$279.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.52

Enterprise value

$286.37M

With a focus on improving patient outcomes through evidence-based healing solutions and services, Sanara MedTech Inc. markets and distributes wound and skin care products and is seeking to offer wound ...

Highlights
SMTI's EPS is up by 48% since the previous quarter and by 48% year-on-year
Sanara MedTech's net income has increased by 47% QoQ and by 46% YoY
SMTI's quick ratio is down by 21% YoY and by 4.8% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://sanaramedtech.com
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of SMTI
Market
Shares outstanding
8.62M
Market cap
$279.72M
Enterprise value
$286.37M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.18
Price to sales (P/S)
4.13
EV/EBIT
N/A
EV/EBITDA
1,502.59
EV/Sales
4.41
Earnings
Revenue
$64.99M
EBIT
-$3.83M
EBITDA
$190,584
Free cash flow
-$3.51M
Per share
EPS
-$0.52
Free cash flow per share
-$0.42
Book value per share
$5.25
Revenue per share
$7.85
TBVPS
$3.06
Balance sheet
Total assets
$73.87M
Total liabilities
$29.28M
Debt
$11.79M
Equity
$44.83M
Working capital
$5.24M
Liquidity
Debt to equity
0.26
Current ratio
1.38
Quick ratio
0.99
Net debt/EBITDA
34.87
Margins
EBITDA margin
0.3%
Gross margin
87.9%
Net margin
-6.6%
Operating margin
-11.8%
Efficiency
Return on assets
-6.4%
Return on equity
-10%
Return on invested capital
-26.9%
Return on capital employed
-6.4%
Return on sales
-5.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SMTI stock price

How has the Sanara MedTech stock price performed over time
Intraday
4.61%
1 week
0.28%
1 month
-6.86%
1 year
-17.35%
YTD
-21.07%
QTD
-12.32%

Financial performance

How have Sanara MedTech's revenue and profit performed over time
Revenue
$64.99M
Gross profit
$57.14M
Operating income
-$7.67M
Net income
-$4.3M
Gross margin
87.9%
Net margin
-6.6%
Sanara MedTech's net margin has surged by 62% YoY and by 50% QoQ
The company's operating margin has surged by 56% YoY and by 13% QoQ
Sanara MedTech's net income has increased by 47% QoQ and by 46% YoY
Sanara MedTech's gross profit has increased by 45% YoY and by 5% QoQ

Growth

What is Sanara MedTech's growth rate over time

Valuation

What is Sanara MedTech stock price valuation
P/E
N/A
P/B
6.18
P/S
4.13
EV/EBIT
N/A
EV/EBITDA
1,502.59
EV/Sales
4.41
SMTI's EPS is up by 48% since the previous quarter and by 48% year-on-year
The price to book (P/B) is 49% lower than the 5-year quarterly average of 12.0 and 19% lower than the last 4 quarters average of 7.6
SMTI's equity is up by 7% year-on-year
The P/S is 46% lower than the 5-year quarterly average of 7.7 and 22% lower than the last 4 quarters average of 5.3
The company's revenue rose by 42% YoY and by 3.8% QoQ

Efficiency

How efficient is Sanara MedTech business performance
Sanara MedTech's return on invested capital has surged by 87% YoY and by 63% QoQ
SMTI's return on sales has surged by 80% year-on-year and by 54% since the previous quarter
The company's return on assets has surged by 59% YoY and by 50% QoQ
The company's return on equity has surged by 52% YoY and by 48% QoQ

Dividends

What is SMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SMTI.

Financial health

How did Sanara MedTech financials performed over time
The company's total assets is 152% higher than its total liabilities
The company's total liabilities has surged by 52% YoY but it fell by 7% QoQ
SMTI's quick ratio is down by 21% YoY and by 4.8% QoQ
Sanara MedTech's debt is 74% lower than its equity
SMTI's equity is up by 7% year-on-year
SMTI's debt to equity is down by 3.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.